Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

By Dena Ettehad, C. Emdin, Amit Kiran, S. Anderson, T. Callender, J. Emberson, J. Chalmers, A. Rodgers, Kazem Rahimi. The Lancet, 2016

2,993 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/fc76a1ebd7756baa3db7e8bdd66b2327326f543b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Michael Holmes
2. J. Bowden
3. P. Whelton

Citations in the corpus

• HIGH BLOOD PRESSURE AND CARDIOVASCULAR DISEASE (2019, positive): “A similar benefit was demonstrated in the relatively large (N=2636) subgroup of participants 75 years or older at baseline, including those with frailty and/or reduced gait speed (41).”
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018, neutral): “5 (20) Fosinopril: 155 (17) ● Mean DBP, mm Hg (SD): Nifedipine GITS: 96 (11) Fosinopril: 96 (8)”